EUVIMEDEUVIMED entdecken
Crossref

Ultrasensitive Detection of FEN1 Activity for Cancer Diagnosis Using a CRISPR/Cas13a‐Based Triple Cascade Amplification System

Xia Cheng, Wenchen Zhao, Daixi Chen, Dandan Ren, Tianwei Qian, Xinyi Xia, Xiaohong Wang, Qijun Li, Jianjun Yang, Yan Gu, Peng Zhang, Kun Yin und 2 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202404411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Xia Cheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Flap Endonucleases, CRISPR-Cas Systems, Biosensing Techniques, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai High-Level Local University construction project, Shanghai 2023 "Science and Technology Innovation Action Plan" Natural Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flap endonuclease 1 (FEN1) is closely associated with tumor progression and proliferation, making it a promising biomarker for cancer diagnosis. However, developing a sensitive, reliable, and user‐friendly method for quantitative FEN1 detection remains technically challenging. In this study, an ultrasensitive FEN1 biosensor is established using a target‐induced cleavage‐ligation‐transcription‐activation cascade strategy (LTACas13a) to enhance the cleavage ability of CRISPR/Cas13a. The LTACas13a method has shown excellent performance in screening FEN1 inhibitors and detecting endogenous FEN1 activity in living cells, as well as in clinical biological samples such as human serum and tissue samples. Additionally, using a universal dumbbell probe derived from FEN1, a multiplex LTACas13a strategy is developed for detecting various DNA glycosylases, including formamidopyrimidine DNA glycosylase, uracil DNA glycosylase, and human alkyl adenine DNA glycosylase. This straightforward approach provides a reliable and effective diagnostic tool for early‐stage cancer detection and offers significant opportunities for FEN1 biosensing and related drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flap EndonucleasesCRISPR-Cas SystemsBiosensing TechniquesNeoplasmsHumansBiomarkers, TumorCell Line, Tumor

Stichwörter der Autor:innen

CRISPR/Cas13aFEN1cancer diagnosiscascade amplificationrolling circle transcription

Substanzen

Flap EndonucleasesFEN1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, 200040, China.
  • Department of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Anhui Provincial Engineering Research Center for dental materials and application, Wannan Medical College, Wuhu, Anhui, 241002, China.

ORCID-Profile: Wenpei Dong

Förderung

  • National Natural Science Foundation of China
  • Shanghai High-Level Local University construction project
  • Shanghai 2023 "Science and Technology Innovation Action Plan" Natural Science Foundation Project
  • NATCM's Project of High-level Construction of Key TCM Disciplines
  • Program for Excellent Sci-tech Innovation Teams of Universities in Anhui Province
  • Clinical Research Foundation of Huadong Hospital
  • the Junior Thousand Talents Program of China

Zitieren

APA

Cheng, X., Zhao, W., Chen, D., Ren, D., Qian, T., Xia, X., Wang, X., Li, Q., Yang, J., Gu, Y., Zhang, P., Yin, K., Yu, P., & Dong, W. (2025). Ultrasensitive Detection of FEN1 Activity for Cancer Diagnosis Using a CRISPR/Cas13a‐Based Triple Cascade Amplification System. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404411

Vancouver

Cheng X, Zhao W, Chen D, Ren D, Qian T, Xia X, et al. Ultrasensitive Detection of FEN1 Activity for Cancer Diagnosis Using a CRISPR/Cas13a‐Based Triple Cascade Amplification System. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404411

BibTeX
@article{Cheng2025,
  author = {Cheng, Xia and Zhao, Wenchen and Chen, Daixi and Ren, Dandan and Qian, Tianwei and Xia, Xinyi and Wang, Xiaohong and Li, Qijun and Yang, Jianjun and Gu, Yan and Zhang, Peng and Yin, Kun and Yu, Ping and Dong, Wenpei},
  title = {Ultrasensitive Detection of FEN1 Activity for Cancer Diagnosis Using a CRISPR/Cas13a‐Based Triple Cascade Amplification System},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202404411}
}
Kostenlos starten →